A Sodium, Fosinopril CEP of the European Pharmacopoeia monograph is often referred to as a Sodium, Fosinopril Certificate of Suitability (COS). The purpose of a Sodium, Fosinopril CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Sodium, Fosinopril EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Sodium, Fosinopril to their clients by showing that a Sodium, Fosinopril CEP has been issued for it. The manufacturer submits a Sodium, Fosinopril CEP (COS) as part of the market authorization procedure, and it takes on the role of a Sodium, Fosinopril CEP holder for the record. Additionally, the data presented in the Sodium, Fosinopril CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Sodium, Fosinopril DMF.
A Sodium, Fosinopril CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Sodium, Fosinopril CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Sodium, Fosinopril suppliers with CEP (COS) on PharmaCompass.